drugset / Trial / NCT03406676
Pre-treatment With Methylene Blue Prevent Peri-operative Reduced Systemic Vascular Resistance
RandomizedParallel-groupDouble-blindPrevention
Summary
To explore the effects of pre-treatment with methylene blue on reduced perioperative vascular resistance in patients with obstructive jaundice.
Timeline
- Start
- 2017-08-01
- Primary completion
- 2018-10-30
- Completion
- 2018-10-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Methylene Blue | Diagnostic / imaging agent | 2 mg/kg | Intravenous |